Funding

Guy Miller

  • 2005 NIH Rapid Access to Intervention Development
    Redox Encrypted Therapeutics for the Treatment of FRDA
    Award: Therapeutic Development Services Agreement
  • 2005 Friedreich’s Ataxia Research Alliance
    Clinical Development of EPI-A0001 for Treatment of FRDA
    Amount: $3M
  • 2005 Muscular Dystrophy Association
    Pre-Clinical Development of EPI-A0001 for Treatment of FRDA
    Amount: $100K
  • 2005 Friedreich’s Ataxia Research Alliance
    Pre-Clinical Development of EPI-A0001 for Treatment of FRDA
    Amount: $300K
  • 2005 United States Department of Defense- Army
    SBIR: Natural Products to Enhance Performance
    Amount: $75 K, Phase I SBIR
  • 2003 Singapore Economic Development Board
    RISC Grant: Redox Encrypted Therapeutics
    Amount: $20M
  • 2003 United Kingdom
    Plant Derived-Natural Products Discovery
    Amount: $1M

Sid Hecht

  • NIH National Cooperative Natural Products Drug Discovery Grant CA50771, Mechanism-Based Discovery of Novel Antitumor Agents
  • NIH Research Grant CA76297, Interaction of Bleomycin with RNA and DNA
  • NIH Research Grant CA77284, Synthesis of Bleomycin Group Antibiotics and Analogues
  • NIH Research Grant CA77359, Elaboration of Modified Proteins Using Misacylated tRNAs
  • NIH Research Grant AI065316, Novel Tools for the Study of HIV-1 RNase H Inhibition